MannKind (MNKD) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
Go back to MannKind (MNKD) Misses Q3 EPS by 1c
November 10, 2015 7:01 AM EST
Piper Jaffray analyst Joshua Schimmer reiterated an Underweight rating and $1.50 price target on MannKind (NASDAQ: MNKD) following results.
Schimmer commented, "While cost-cutting measures will help curtail the cash burn, the disappointing launch of Afrezza and increasing net-debt position seem to be making the... More
November 9, 2015 11:29 AM EST
In addition to poor earnings, MannKind (NASDAQ: MNKD) investors are reacting to the ominous sign from Leerink Partners' Sanofi (NYSE: SNY) analyst Seamus Fernandez.
Fernandez removed Afrezza estimates from their Sanofi 2016 model and... More
November 9, 2015 11:26 AM EST
MannKind (NASDAQ: MNKD) was mentioned cautiously on Twitter by theStreet columnist Adam Feuerstein.
. @shaneblackmon $MNKD has to address the bankruptcy question on tonights call. Theyre very close to insolvency. How will co. survive?
Adam Feuerstein (@adamfeuerstein)
November 9, 2015
...
More
